| NEWSLETTER
- SEPTEMBER 2007 |
|
 |
| |
|
International
Specialty Pharmaceutical
Company Chooses Ashton Tweed to Source Key Positions for Its
Expanding U.S. Operations
Ashton Tweed is pleased to announce the addition of a new international specialty pharmaceutical company
to our client roster. Our new client, headquartered in Montreal, Canada, is an emerging leader in drug delivery and is expanding
its U.S. commercial operations in the Greater Philadelphia region.
"We are pleased to welcome another international client beginning
operations in the United States. In choosing Ashton Tweed,
our client leverages the benefits of multiple hiring options
including targeted executive search, interim placement, and
interim-to-hire services. Both targeted searches and our Executive
Talent Bank consisting of highly experienced professionals
in key life sciences job functions will be utilized to provide
the best talent for our new client's U.S. operations," said
Ashton Tweed CEO Jim Rudman.
Ashton Tweed is recruiting for four Strategic Marketing positions, covering the EU, Latin America/Australasia, North America
and New Product Development for CNS product lines. The roles require 7-10+ years of pharmaceutical/biotechnology industry experience
in worldwide strategic marketing with an emphasis on markets outside the U.S. and report directly to the president. Qualified candidates
are invited to submit their resumes to info@ashtontweed.com.
To learn more about Ashton Tweed and our Executive Talent Bank, please visit www.ashtontweed.com/executive_bank.php.
Back to top |
|
|
The ASHTON TWEED DIFFERENCE
Immediate access to highly
skilled talent
through the first Executive Talent Bank dedicated to the Life
Sciences Industry.
Diverse range of options for
human capital and commercialization management needs
- interim talent, retained executive search and commercialization
consulting.
Significant Life Sciences
Industry experience
from partners with diverse backgrounds in the Life Sciences
Industry and who understand the specific challenges Life Sciences
clients face.
Personal attention where
each client and candidate receives personal attention by a
member of our Leadership Team.
|
|
 |
| UPCOMING EVENTS
Look for BioPortUSA at Upcoming International Conferences
AusBiotech
Representatives from BioPortUSA, a commercialization accelerator for life sciences companies entering
the United States market, will be attending the AusBiotech National Biotechnology Conference and
Business Partnering and Investment Forum October 21-24 in Queensland, Australia. If you are planning to
attend Ausbiotech, please look for BioPortUSA on the
online partnering system and reserve a time to say hello.
The AusBiotech conference:
- Combines a comprehensive conference program and an extensive BioIndustry
Exhibition and Business Partnering & Investment Forum
- Is attended by over 1300 delegates
- Features over 120 exhibition booths
For more information on the conference and to register, please visit the conference website.
|
|
Ashton
Tweed Launches Free Report on Reimbursement
Ashton Tweed has launched the first in a new series of industry reports authored by experts from our Executive Talent Bank.
Roadmap to Reimbursement, by Fortune 100 reimbursement executive William Ashton, highlights ways companies can avoid common
pitfalls and begin to build a complete, effective reimbursement strategy to maximize ROI.
The free report, which is available as a PDF download from our website, discusses:
- How to ensure that your product achieves a highly desired reimbursement status over its life cycle;
- How to develop a winning strategy for private insurance reimbursement; and
- How to avoid the pitfalls of the government funded reimbursement system.
The reimbursement status of a product is a significant factor in determining its potential patient population and is a core aspect of
securing maximum ROI. Ironically, many executives polled by Datamonitor stated that their companies were failing to commit adequate
time and resources to handling their reimbursement challenges. Roadmap to Reimbursement offers guidance for life sciences
companies on developing an effective reimbursement strategy to cover a product's complete life cycle.
"We believe Roadmap to Reimbursement will be a useful guide for companies planning and developing reimbursement strategies
and that the report meets a need for clear information on navigating the private and public reimbursement systems," said Jim Rudman,
CEO, Ashton Tweed. "We look forward to continuing our series of reports by our Executive Talent Bank experts on topics that affect
the way life sciences companies do business."
Roadmap to Reimbursement's author, Bill Ashton, is a Fortune 100 senior executive with over seventeen years experience in Biotechnology
management. After a lengthy career at Amgen Inc., the world’s largest biotech firm, Bill took early retirement in 2005. During his final
executive assignment, he served as VP of Commercial Affairs and Reimbursement (2003 – 2005) and was directly responsible for strategy
development and corporate activities designed for key government agencies including: Centers for Medicare and Medicaid Services, Office of
Inspector General, Government Accountability Office, Office of Management and Budget, and MedPAC. Bill is currently an Associate Professor
at the University of the Sciences in Philadelphia.
The report is free and you can request a copy either by visiting our website (www.ashtontweed.com)
or by calling us at 610-725-0290 x 446.
Back to top |
|
| UPCOMING
EVENTS Look for BioPortUSA
at Upcoming International Conferences
BIO-Europe
BioPortUSA will also be at the BIO-Europe 13th Annual International
Partnering Conference in Hamburg, Germany, November 12-14.
The BIO-Europe conference:
- Brings together international decision-makers
from the biotechnology, pharmaceutical and financial sectors
- Offers networking opportunities,
including over 7,000 one-to-one meetings
- Includes 19 workshops and panels
- Has 66 international exhibitors
- Features 194 pharma and biotech
company presentations
For more information on the conference
and to register, please visit the event website. |
|
|
| UPCOMING
EVENTS Biotech 2007 DE
NJ PA
October 8-9, 2007
Loews Philadelphia Hotel, Philadelphia, PA
Biotech 2007 is designed to advance the growth and development
of the bioscience industry in the Mid-Atlantic region and
will facilitate networking opportunities among emerging companies,
researchers, and large pharmaceutical companies, as well as
with cutting-edge support organizations. The conference will
include 21 panel discussions, thought-provoking plenary sessions,
dynamic keynote speakers, a business development forum, innovation
corridor, career fair, and exhibit hall.
For more information, please visit www.biotech2007.org. |
|
Ashton
Tweed Partners Share
their Support at the Cystic Fibrosis Foundation's Golf Outing
On August 30, 2007, Ashton Tweed partners Jim Rudman and Jim Laird
participated in the Nineteenth Annual Duffers' and Pros' Golf Tournament to Benefit the Cystic Fibrosis Foundation.
The tournament, held at the Pine Hill Golf Course in Pine Hill, New Jersey, featured 62 golfers united to support
Cystic Fibrosis research.
The tournament began in 1989 when its founder, Bill Maffucci, wanted to create an event that could help fund the fight
to cure cystic fibrosis and also appeal to weekend golfers who might be reticent to participate in the more competitive
fundraising tournaments already in existence. The event has grown steadily over the past nineteen years, and this year's
tournament featured 60 hole sponsors, including Ashton Tweed, and raised approximately $10,000 for the CF Foundation.
Ashton Tweed partners Jim Laird and Jim Rudman with Lisa Goldsborough of Pennsylvania Bio
at the Ashton Tweed sponsored hole (photo by teammate Dom Vacca)
The Cystic Fibrosis Foundation is the leading organization in the United States devoted to developing the means to cure
and control cystic fibrosis and improve the quality of life for those with the disease. The CF Foundation has more than
80 chapters and branch offices nationwide. The foundation also funds and accredits 115 CF care centers across the country
that provide patients and families with treatment and other CF resources.
"We were pleased to gather a foursome including Lisa Goldsborough of Pennyslvania Bio, Dom Vacca of Acsys, and my partner
Jim Laird to participate in the tournament and to support this event by sponsoring a hole. We are grateful for the
opportunity to support the work the CF Foundation is doing to fund breakthrough research and improve the lives of those
with cystic fibrosis, and we look forward to next year’s successful tournament," said Ashton Tweed CEO Jim Rudman.
To learn more about the CF Foundation and advances in Cystic Fibrosis research, please visit www.cff.org.
Back to top
|
|
|
UPCOMING
EVENTS 2nd Annual Hubert
J.P. Schoemaker Classic Golf Tournament
October 22, 2007
The tournament will be held on October 22nd at Waynesborough
Country Club in Paoli, PA and White Manor Country Club in
Malvern, PA, and:
- The golf outing, gala dinner,
and auction honor the memory of Hubert J.P. Schoemaker,
Philadelphia biotech leader and former CEO of Centocor
- Proceeds benefit Melmark, a comprehensive
multi-service agency for children and adults with developmental
disabilities
For sponsorship opportunities and
more information, please contact event organizer Kevin Scanlon
at kmssports@msn.com
or 610-566-1171.
|
|
|
| UPCOMING
EVENTS 2007 Mid-Atlantic
Bio
October 24-26
Bethesda, MD
Investors and exhibitors will have the
chance to attend company presentations, participate in panels
and learn about leading developments in their fields. Keynote
speakers include Nobel Laureate Dr. Thomas Cech, AstraZeneca
CEO David Brennan and Biogen Idec CEO Jim Mullen.
For more information and to register, please visit the event
website. |
|
Ashton
Tweed Sponsors Pennsylvania Bio August Panel and Networking
Event
Ashton Tweed was pleased to be among the sponsors of Pennsylvania Bio's Board Development and Corporate Governance
event on August 15, 2007. The event which was attended by 120 people at the Desmond Hotel in Malvern, PA brought
together heads of companies and venture capitalists to discuss topics including board of directors creation, retention, and change.
This panel explored the development, evolution, and strategic impact of boards of directors of bioscience companies.
The event's speakers included Elaine Jones, Ph.D., general partner, EuclidSR Partners; D. Lansing Taylor, Ph.D., president
and CEO, Cellumen, Inc.; Robert Towarnicki, president & CEO, Nucleonics, Inc., and David U'Prichard, Ph.D., venture partner,
Red Abbey Venture Partners.
The panelists engaged in a lively dialogue on board composition, characteristics, and best practices for corporate governance.
Attendees benefited from a well-rounded discussion including the perspectives of both panelists who had served on and created
board of directors and those who had served as presidents of companies governed by boards. At the panel’s conclusion, attendees
enjoyed the event's networking reception.
To learn more about other upcoming Pennsylvania Bio events, please visit www.pennsylvaniabio.org/.
Back to top
|
|
| UPCOMING
EVENTS 7th International
Stem Cell Conference
October 29-30, 2007
Pittsburgh, PA
The conference features the latest diagnostic and therapeutic
research updates plus structured sessions facilitating networking
with the FDA, NIH and leading researchers. The meeting also
offers Partnership Development and Global Commercialization
Strategies to help attendees establish partnerships, attract
funding and gain investor attention to spur products from
early stage through clinical trials.
For more information and to register, please visit the conference
website. |
|
|
